معرفی
Marlies Baars is a Researcher in the Neurology department at Erasmus University Medical Center, with extensive expertise in neurological and immunological research. Her work primarily focuses on autoimmune neuromuscular diseases and their interaction with SARS-CoV-2 vaccinations and infections.
Her research interests span Neurology, Immunology, and Autoimmune Diseases, with particular emphasis on patient outcomes following vaccinations in immunocompromised populations. Her fingerprint analysis reveals strong expertise in Severe Acute Respiratory Syndrome Coronavirus 2 (100%), Immune-Mediated Inflammatory Diseases (70%), and COVID-19 Vaccination (53%).
Analysis of her recent publications shows a clear research trajectory examining how patients with neurological and autoimmune conditions respond to SARS-CoV-2 infections and vaccinations. Her work often involves multi-center collaborations as evidenced by large author lists on her publications. She has made significant contributions to understanding humoral immunity, breakthrough infections, and patient-reported outcomes in vulnerable populations.
Her scientific contributions include 17 research outputs (14 articles, 2 comment/letters, and 1 review article) with recent publications appearing in high-impact journals such as Annals of Neurology, Journal of Allergy and Clinical Immunology, and European Journal of Neurology.
Dr. Baars actively collaborates with researchers across multiple institutions through initiatives like the T2B Immunity against SARS-CoV-2 study group, demonstrating her engagement in large-scale collaborative research efforts focused on understanding immune responses in various patient populations.
